Skip to content
Tuesday, 17 November 2026, Lagos
Health

NAFDAC Mandates Bioequivalence Studies to Strengthen Drug Safety Standards

By Elias Sanusi
NAFDAC Mandates Bioequivalence Studies to Strengthen Drug Safety Standards

In a decisive move to enhance public confidence in generic medicines and align Nigeria’s pharmaceutical industry with global standards, the National Agency for Food and Drug Administration and Control (NAFDAC) has mandated bioequivalence studies for all generic drugs produced or imported into the country. This regulatory shift was announced by NAFDAC’s Director General, Professor Mojisola Adeyeye, during a press briefing on Thursday in Lagos.

The new policy aims to eliminate substandard and ineffective medications from the Nigerian market by ensuring that generic drugs match their branded counterparts in therapeutic efficacy and clinical performance. Bioequivalence studies are scientific evaluations that confirm whether a generic medicine delivers the same dosage of active ingredients as its brand-name equivalent, with similar safety and efficacy outcomes. Prof. Adeyeye emphasized that this initiative would boost trust in generic medications while promoting rational prescription practices.

“By mandating bioequivalence studies, NAFDAC is strengthening its regulatory framework to safeguard public health. This measure enhances trust in generic medicines, promotes rational prescription practices, and aligns Nigeria with global pharmaceutical standards,” Adeyeye stated.

To ensure smooth implementation, NAFDAC has launched a strategic roadmap that includes issuing detailed regulatory guidelines for Contract Research Organizations (CROs) conducting these studies. These guidelines, along with a “Note to Industry,” have been made publicly accessible through NAFDAC’s official website. The agency is also investing in capacity building by organizing nationwide training sessions for healthcare professionals, researchers, and pharmaceutical companies to ensure unified understanding of bioequivalence requirements.

Despite the positive reception of this policy within the healthcare sector, challenges remain. Nigeria currently lacks sufficient bioequivalence laboratories, which poses hurdles for local manufacturers and researchers. Stakeholders will need to invest heavily in clinical trials and advanced testing methodologies to meet NAFDAC’s stringent standards. However, this regulation is expected to drive collaboration between pharmaceutical companies and research institutions while fostering innovation within the industry.

The mandatory inclusion of bioequivalence data in drug registration dossiers is set to take effect by January 2026 for both locally manufactured and imported products. This phased implementation will initially focus on essential drug classes such as antimalarials, antibiotics, and treatments for neglected tropical diseases.

NAFDAC’s bold regulatory update reflects its commitment to creating a safer pharmaceutical environment for Nigerians while positioning the country’s industry for international competitiveness. By enforcing rigorous scientific evaluations, the agency aims to elevate Nigeria’s drug safety standards and reduce reliance on imported medicines. As Prof. Adeyeye aptly noted, “Collaborative efforts between healthcare institutions, professionals, and manufacturers are crucial to building a reliable regulatory system that guarantees safe and effective medications for all Nigerians.”

Related stories

Experts Warn: Sugary Drinks Raise Risk of Heart Disease in Children

Health experts have cautioned that regular consumption of sugary beverages can significantly increase the risk of heart disease in children, highlighting growing concerns over childhood nutrition and lifestyle habits. Studies indicate that drinks high in added sugar contribute to obesity, elevated…

NAFDAC Clears Nestlé Infant Formula Sold in Nigeria Amid UK Recall

The National Agency for Food and Drug Administration and Control has assured Nigerians that Nestlé infant formula products available in the country are safe and not affected by the recent product recall announced in the United Kingdom. The clarification follows concerns raised by consumers after…

Health Workers Insist Strike Action Will Continue Amid Unresolved Demands

Health workers across the country have declared their intention to sustain the ongoing strike, citing the failure of authorities to adequately address their outstanding demands. Union leaders said the decision followed consultations with members, who resolved that industrial action would remain in…

Doctors Call for Enhanced Welfare to Stem Brain Drain

Medical professionals across Nigeria are urging the government to improve their welfare and working conditions as a strategy to curb the ongoing “japa” trend, where skilled doctors leave the country in search of better opportunities abroad. They highlighted that poor remuneration, inadequate…